Positioned in Maryland’s premier biotech corridor, the GMP manufacturing campus at 8000 & 9000 Virginia Manor Road offers a rare opportunity to lease a fully validated, state-of-the-art facility designed for clinical and commercial biomanufacturing. With 31,308 SF available across two suites, this turnkey space is engineered for scalability, compliance, and innovation. Suite 200 at Building 9000 features 26,305 SF of GMP manufacturing space, including GLP, microbiology, development, and analytical/QC labs. Suite 180 at Building 8000 offers 5,003 SF of GMP warehouse and storage, ideal for controlled material handling and logistics.
The facility includes Sartorius STR single-use bioreactors (2 x 1000L, 2 x 200L), a 3,000L WFI system, in-suite autoclave, AKTA chromatography skids, and validated cold room and cleanroom environments. Infrastructure supports uninterrupted operations with emergency backup power, clean compressed gases, and electronic batch record systems. Located just 0.5 miles from MARC Rail and within 20–35 miles of three major airports, the site offers unmatched connectivity. Proximity to the FDA, NIH, and University of Maryland further enhances its strategic value for life sciences firms.
Designed by Gaudreau, Inc. and built by JennErik Engineering, the facility has supported production of 16 GMP batches and materials for five INDs. Expansion potential includes antibody drug conjugation and master cell banking. This is a rare chance to secure long-term, high-performance space in one of the nation’s most dynamic biotech regions.
Frank Graybeal
CBRE
